Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters

Florath I, Albert A, Hassanein W, Arnrich B, Rosendahl U, Ennker IC, Ennker J (2006)
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY 30(5): 716-721.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Konferenzbeitrag | Veröffentlicht | Englisch
Autor
; ; ; ; ; ;
Abstract / Bemerkung
Objective: Haematological and biochemical measurements are performed routinely before surgery to exclude organ malfunction and blood cell and coagulation abnormalities. We aimed to test routinely obtained laboratory data as factors predicting operative risk. Methods: Between 1996 and 2003, 2198 patients underwent aortic valve replacement (AVR) (908 of them with concomitant CABG) in our institute. The mean age of the study population was 69 +/- 11 years (range 13-91, 43% female). Clinical and laboratory parameters based on the consolidated data mart set were evaluated by multiple logistic regression analysis. Results: The overall operative mortality (within 30 days) was 3.8% and the mortality after 3 months was 5.9%. In addition to clinical characteristics, the following laboratory values were identified as independent predictors of 30-day mortality: fasting blood glucose, antithrombine III, partial thromboplastine time and creatinine kinase. As independent predictors of 3-month mortality, the following laboratory values were indentified: fasting blood glucose, serum creatinine, antithrombine III, partial thromboplastine time, lactate dehydrogenase, sodium concentration and serum proteins. The discriminative power of the models increased if laboratory parameters were included in addition to preoperative clinical characteristics (from 0.75 to 0.79 and from 0.75 to 0.78 for 30-day and 3-month mortality, respectively). The discriminative power using the logistic EuroScore was tower (0.71 and 0.7, for 30-day and 3-month mortality, respectively). Conclusions: Laboratory parameters as objective markers for organ function and nutritional status are useful data for the prediction of 30-day and 3-month mortality after aortic valve replacement. Using modern methods of information technology, these valuable data which are stored electronically in most hospitals, can be used efficiently for research and quality control. (c) 2006 Elsevier B.V. All rights reserved.
Erscheinungsjahr
Band
30
Ausgabe
5
Seite(n)
716-721
ISSN
PUB-ID

Zitieren

Florath I, Albert A, Hassanein W, et al. Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2006;30(5):716-721.
Florath, I., Albert, A., Hassanein, W., Arnrich, B., Rosendahl, U., Ennker, I. C., & Ennker, J. (2006). Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 30(5), 716-721. doi:10.1016/j.ejcts.2006.08.009
Florath, I., Albert, A., Hassanein, W., Arnrich, B., Rosendahl, U., Ennker, I. C., and Ennker, J. (2006). Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY 30, 716-721.
Florath, I., et al., 2006. Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 30(5), p 716-721.
I. Florath, et al., “Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters”, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, vol. 30, 2006, pp. 716-721.
Florath, I., Albert, A., Hassanein, W., Arnrich, B., Rosendahl, U., Ennker, I.C., Ennker, J.: Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 30, 716-721 (2006).
Florath, Ines, Albert, Alexander, Hassanein, Wael, Arnrich, Bert, Rosendahl, Ulrich, Ennker, Ina C., and Ennker, Jürgen. “Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters”. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY 30.5 (2006): 716-721.

11 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Implementation of an automated early warning scoring system in a surgical ward: Practical use and effects on patient outcomes.
Mestrom E, De Bie A, Steeg MV, Driessen M, Atallah L, Bezemer R, Bouwman RA, Korsten E., PLoS One 14(5), 2019
PMID: 31067229
Antithrombin III is associated with acute liver failure in patients with end-stage heart failure undergoing mechanical circulatory support.
Hoefer J, Ulmer H, Kilo J, Margreiter R, Grimm M, Mair P, Ruttmann E, Innsbruck Liver-in-Heart-Failure Program., J Thorac Cardiovasc Surg 153(6), 2017
PMID: 28274560
Reversibility of chronic kidney disease and outcomes following aortic valve replacement†.
Najjar M, Yerebakan H, Sorabella RA, Guglielmetti L, Vandenberge J, Kurlansky P, Williams MR, Argenziano M, Smith CR, George I., Interact Cardiovasc Thorac Surg 21(4), 2015
PMID: 26180091
Common laboratory tests predict imminent death in ward patients.
Loekito E, Bailey J, Bellomo R, Hart GK, Hegarty C, Davey P, Bain C, Pilcher D, Schneider H., Resuscitation 84(3), 2013
PMID: 22863543
Performance of the original EuroSCORE.
Siregar S, Groenwold RH, de Heer F, Bots ML, van der Graaf Y, van Herwerden LA., Eur J Cardiothorac Surg 41(4), 2012
PMID: 22290922
Impact of New York Heart Association classification, advanced age and patient-prosthesis mismatch on outcomes in aortic valve replacement surgery.
Zapolanski A, Mak AW, Ferrari G, Johnson C, Shaw RE, Brizzio ME, Sperling JS, Grau JB., Interact Cardiovasc Thorac Surg 15(3), 2012
PMID: 22665381
Aortic valve replacement: results and predictors of mortality from a contemporary series of 2256 patients.
Di Eusanio M, Fortuna D, De Palma R, Dell'Amore A, Lamarra M, Contini GA, Gherli T, Gabbieri D, Ghidoni I, Cristell D, Zussa C, Pigini F, Pugliese P, Pacini D, Di Bartolomeo R., J Thorac Cardiovasc Surg 141(4), 2011
PMID: 20599229
Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement.
Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PD, Dara AB, Puskas JD, Chen EP, Cooper WA, Vega JD, Morris CD, Halkos ME, Lattouf OM., Ann Thorac Surg 91(6), 2011
PMID: 21536247
EuroSCORE performance in valve surgery: a meta-analysis.
Parolari A, Pesce LL, Trezzi M, Cavallotti L, Kassem S, Loardi C, Pacini D, Tremoli E, Alamanni F., Ann Thorac Surg 89(3), 2010
PMID: 20172129
The relationship between renal function and outcome from heart valve surgery.
Gibson PH, Croal BL, Cuthbertson BH, Chiwara M, Scott AE, Buchan KG, El-Shafei H, Gibson G, Jeffrey RR, Hillis GS., Am Heart J 156(5), 2008
PMID: 19061703

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 16965919
PubMed | Europe PMC

Suchen in

Google Scholar